LONA CIK: 1620463

LeonaBio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
261
FY22:
208
FY23:
155
FY24:
54.8
FY25:
89.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
71.2
FY22:
50.6
FY23:
5.52
FY24:
3.94
FY25:
2.69
Total assets
Change from FY21 to FY25
millions USD
FY21:
332
FY22:
258
FY23:
160
FY24:
58.8
FY25:
92.2

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
9.29
FY22:
21.4
FY23:
28.8
FY24:
13.1
FY25:
47.5
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.63
FY22:
1.59
FY23:
1.22
FY24:
0.80
FY25:
16.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
321
FY22:
235
FY23:
130
FY24:
44.8
FY25:
27.8
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
332
FY22:
258
FY23:
160
FY24:
58.8
FY25:
92.2

All amounts in millions USD Data source:SEC EDGAR